Chimerix(us:CMRX)

    2.97

    -0.67%

    Updated on 2024-12-23

    Open:3.14
    Close:2.97
    High:3.17
    Low:2.91
    Pre Close:2.99
    Volume:786340.00
    Amount:2.37M
    Turnover:0.87%
    Shares:89.94M
    MarketCap:267.11M

    About Chimerix Company

    Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

    Company Name: Chimerix
    Company Address: 2505 Meridian Parkway,Suite 100
    Employees: 72
    Fiscar Year: 12-31
    IPO Date:
    CIK: 1117480

    View all SEC Filings

    About

    Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
    Address:2505 Meridian Parkway,Suite 100

    Market Movers